AT20 KLHAlternative Names: AIDS vaccine - Medestea; AT20-KLH; HIV vaccine - Medestea; p17 based immunogen - Medestea
Latest Information Update: 06 Jan 2016
At a glance
- Originator Medestea
- Class Peptide vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I HIV infections
Most Recent Events
- 05 Jan 2016 Medestea completes a phase I trial in HIV infections in Italy before January 2016